Board / shareholder meeting outcomeFiled on NSE ·

Q-Line Biotech Limited holds 16th AGM, reports FY 2025-26 financials and reappointments

Q-Line Biotech Ltd · Healthcare Equipment & Supplies

What the filing says

  • FY 2025-26 revenue ₹341.74 crore; Profit After Tax ₹55.72 crore, up from ₹19.21 crore previous year
  • Re-appointment of directors Mr. Ajay Kumar Mahanty and Mr. Kuldeep Chowdhry approved
  • New manufacturing facility at Lucknow commissioned and operational since May 29, 2026 listing on NSE Emerge

Original filing

Shareholders meeting

Read the filing on NSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies

Electrical Equipment

Revenue: Rank 1Margin: Rank 1

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Other board / shareholder meeting outcome filings this fortnight

All board / shareholder meeting outcome filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.